methylthio-adp has been researched along with glyburide in 3 studies
Studies (methylthio-adp) | Trials (methylthio-adp) | Recent Studies (post-2010) (methylthio-adp) | Studies (glyburide) | Trials (glyburide) | Recent Studies (post-2010) (glyburide) |
---|---|---|---|---|---|
146 | 2 | 43 | 6,554 | 620 | 1,344 |
Protein | Taxonomy | methylthio-adp (IC50) | glyburide (IC50) |
---|---|---|---|
ATP-binding cassette sub-family C member 9 | Homo sapiens (human) | 0.22 | |
Bile salt export pump | Rattus norvegicus (Norway rat) | 5.7 | |
Bile salt export pump | Homo sapiens (human) | 5.5333 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 1.602 | |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.0043 | |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.1121 | |
NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | 10 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barr, HM; Camden, J; Eliahu, S; Fischer, B; Weisman, GA | 1 |
Barr, HM; Camden, J; Fischer, B; Shai, E; Varon, D; Weisman, GA; Yelovitch, S | 1 |
Bagorda, A; Calamita, G; Casavola, V; Fanelli, T; Favia, M; Guerra, L; Jacobson, KA; Reshkin, SJ; Svetlo, M | 1 |
3 other study(ies) available for methylthio-adp and glyburide
Article | Year |
---|---|
A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.
Topics: Alkaline Phosphatase; Animals; Blood Glucose; Cell Line, Tumor; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Fasting; Humans; Insulin; Insulin Secretion; Male; Molecular Structure; Purinergic P2 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Serum; Structure-Activity Relationship | 2010 |
Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.
Topics: Animals; Blood Glucose; Cell Line, Tumor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred ICR; Molecular Structure; Purinergic P2Y Receptor Agonists; Rats; Rats, Wistar | 2012 |
Stimulation of Xenopus P2Y1 receptor activates CFTR in A6 cells.
Topics: Adenosine Diphosphate; Animals; Calcium; Cell Line; Chlorides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Glyburide; Indomethacin; Isoquinolines; Kidney Tubules; Phosphoproteins; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Sodium-Hydrogen Exchangers; Sulfonamides; Thionucleotides; Xenopus laevis | 2004 |